Episode 111: PREMIUM – New stuff you really need to know about
In episode 111, Mike and James bring you the premier edition of the new PREMIUM TEC podcast episodes. We discuss high dose versus low dose statins, we possibly put the final nail in the rosiglitazone coffin and finally report that single high annual doses of Vitamin D didn’t do what they were supposed to do. At the end we discuss whether or not the PREMIUM label really should have been given to this podcast and decide to let the listeners make that decision.
Show notes
1) SEARCH – low dose (20 mg) vs high dose (80 mg) simvastatin in patients after an MI
2) Rosiglitazone – are we really done with it?
ACP Journal Club 2007Nov-Dec;147:66
Arch Intern Med 2010;170(14):1191-1201
Food and Drug Administration. Briefing document:July13-14,2010 meeting of the
Endocrinologic and Metabolic Drugs Advisory Committee
BMJ 2010;340:c1344.doi:10.1136/bmj.c1344
3) Annual high-dose (500,000 IU) oral Vitamin D and falls and fractures in older women
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
